EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia: From Serendipity to Precision Biological Ablation

Zhoushan Gu iD, Zhou Xu iD, Youmei Shen iD, Linsheng Shi iD, Hailei Liu iD, Minglong Chen iD

Reviews in Cardiovascular Medicine · 22.07.2026 · 27 (7)

DOI: 10.31083/rcm49589 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 22.07.2026. Verfasst von Zhoushan Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Hospital of Nantong University, 226001 Nantong, Jiangsu, China. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ventricular arrhythmias (VAs), particularly refractory ventricular tachycardia (VT), pose a significant therapeutic challenge and are associated with high morbidity and mortality. For patients who do not respond to conventional therapies, including antiarrhythmic drugs and catheter ablation (CA), stereotactic body radiotherapy (SBRT)—also known as stereotactic arrhythmia radioablation (STAR)—has emerged as a promising non-invasive alternative. This review synthesizes current clinical evidence from prospective trials, retrospective series, and case reports that collectively demonstrate the efficacy of STAR in reducing VT burden and improving quality of life. This review also explores the evolving understanding of the associated underlying biological mechanisms, which appear to involve a complex interplay between early electrophysiological conduction reprogramming and delayed structural myocardial remodeling mediated by inflammation and fibrosis. Finally, we address the critical technical considerations, including patient selection, target delineation using multimodal imaging and electroanatomic mapping, motion management, and treatment planning, which are essential for the safe and effective delivery of STAR. While short-term outcomes are encouraging, ongoing research is needed to optimize dosing, refine techniques, and establish long-term efficacy and safety.

Schlagwörter

Stichwörter der Autor:innen

arrhythmia substratecardiac radioablationelectrophysiological remodelingmyocardial fibrosisstereotactic body radiotherapyventricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Hospital of Nantong University, 226001 Nantong, Jiangsu, China.
  • Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, Jiangsu, China.

ORCID-Profile: Zhoushan Gu, Zhou Xu, Youmei Shen, Linsheng Shi, Hailei Liu, Minglong Chen

Zitieren

APA

Gu, Z., Xu, Z., Shen, Y., Shi, L., Liu, H., & Chen, M. (2026). Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia: From Serendipity to Precision Biological Ablation. Reviews in Cardiovascular Medicine, 27(7). https://doi.org/10.31083/rcm49589

Vancouver

Gu Z, Xu Z, Shen Y, Shi L, Liu H, Chen M. Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia: From Serendipity to Precision Biological Ablation. Reviews in Cardiovascular Medicine. 2026;27(7). doi:10.31083/rcm49589

BibTeX
@article{Gu2026,
  author = {Gu, Zhoushan and Xu, Zhou and Shen, Youmei and Shi, Linsheng and Liu, Hailei and Chen, Minglong},
  title = {Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia: From Serendipity to Precision Biological Ablation},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {7},
  doi = {10.31083/rcm49589}
}
Kostenlos starten →